KTTA icon

Pasithea Therapeutics

10 hedge funds and large institutions have $662K invested in Pasithea Therapeutics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
KPF
1
K2 Principal Fund
Ontario, Canada
$497K 491,797 -58,203 -11%
Vanguard Group
2
Vanguard Group
Pennsylvania
$79K 78,139 +21,556 +38%
State Street
3
State Street
Massachusetts
$24K 23,647 +23,647 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$19K 19,726 +19,726 New
VF
5
Virtu Financial
New York
$15K 14,571 +14,571 New
UBS Group
6
UBS Group
Switzerland
$13K 12,805 +12,805 New
SG
7
StoneX Group
New York
$12.1K 12,000 +12,000 New
TRCT
8
Tower Research Capital (TRC)
New York
$2K 2,254 +2,254 New
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$1K 1,000
Citadel Advisors
10
Citadel Advisors
Florida
-72,937 Closed
MSFP
11
Mark Sheptoff Financial Planning
Connecticut
-48,000 Closed
TSS
12
Two Sigma Securities
New York
-18,899 Closed
BlackRock
13
BlackRock
New York
-9,962 Closed
CFGS
14
Concourse Financial Group Securities
Alabama
Wells Fargo
15
Wells Fargo
California
$0 95 +11 +13%